We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gear Up for Aflac (AFL) Q2 Earnings: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Aflac (AFL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.71 per share, reflecting a decline of 6.6% compared to the same period last year. Revenues are forecasted to be $4.43 billion, representing a year-over-year decrease of 13.7%.
The consensus EPS estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Aflac metrics that are commonly monitored and projected by Wall Street analysts.
Analysts expect 'Revenues- Other income (loss)' to come in at $29.80 million. The estimate suggests a change of +35.5% year over year.
The consensus among analysts is that 'Revenues- Net investment income' will reach $907.26 million. The estimate suggests a change of -17.2% year over year.
The consensus estimate for 'Revenues- Total net earned premiums' stands at $3.44 billion. The estimate indicates a year-over-year change of +3.4%.
The collective assessment of analysts points to an estimated 'Total adjusted revenues- Corporate and other' of $328.50 million. The estimate points to a change of +31.9% from the year-ago quarter.
Analysts forecast 'Total adjusted revenues- Aflac Japan' to reach $2.38 billion. The estimate suggests a change of -2.6% year over year.
The average prediction of analysts places 'Total adjusted revenues- Aflac Japan- Total net earned premiums' at $1.77 billion. The estimate suggests a change of +3.2% year over year.
It is projected by analysts that the 'Total adjusted revenues- Aflac Japan- Net investment income' will reach $615.74 million. The estimate points to a change of -15.9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Total adjusted revenues- Aflac U.S.- Other income' should arrive at $15.00 million. The estimate indicates a change of +36.4% from the prior-year quarter.
The combined assessment of analysts suggests that 'Total Benefit /Premium - Aflac Japan' will likely reach 65.3%. The estimate is in contrast to the year-ago figure of 66.9%.
According to the collective judgment of analysts, 'Total Adjusted Expenses/Total Adjusted Revenue - Aflac U.S.' should come in at 38.1%. Compared to the current estimate, the company reported 36.9% in the same quarter of the previous year.
Analysts' assessment points toward 'Total Benefit /Premium - Aflac U.S.' reaching 47.8%. The estimate compares to the year-ago value of 46.7%.
Analysts predict that the 'Total Adjusted Expenses/Total Adjusted Revenue - Aflac Japan' will reach 19.7%. The estimate is in contrast to the year-ago figure of 17.8%.
Over the past month, shares of Aflac have returned -4.8% versus the Zacks S&P 500 composite's +2.7% change. Currently, AFL carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Gear Up for Aflac (AFL) Q2 Earnings: Wall Street Estimates for Key Metrics
In its upcoming report, Aflac (AFL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.71 per share, reflecting a decline of 6.6% compared to the same period last year. Revenues are forecasted to be $4.43 billion, representing a year-over-year decrease of 13.7%.
The consensus EPS estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Aflac metrics that are commonly monitored and projected by Wall Street analysts.
Analysts expect 'Revenues- Other income (loss)' to come in at $29.80 million. The estimate suggests a change of +35.5% year over year.
The consensus among analysts is that 'Revenues- Net investment income' will reach $907.26 million. The estimate suggests a change of -17.2% year over year.
The consensus estimate for 'Revenues- Total net earned premiums' stands at $3.44 billion. The estimate indicates a year-over-year change of +3.4%.
The collective assessment of analysts points to an estimated 'Total adjusted revenues- Corporate and other' of $328.50 million. The estimate points to a change of +31.9% from the year-ago quarter.
Analysts forecast 'Total adjusted revenues- Aflac Japan' to reach $2.38 billion. The estimate suggests a change of -2.6% year over year.
The average prediction of analysts places 'Total adjusted revenues- Aflac Japan- Total net earned premiums' at $1.77 billion. The estimate suggests a change of +3.2% year over year.
It is projected by analysts that the 'Total adjusted revenues- Aflac Japan- Net investment income' will reach $615.74 million. The estimate points to a change of -15.9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Total adjusted revenues- Aflac U.S.- Other income' should arrive at $15.00 million. The estimate indicates a change of +36.4% from the prior-year quarter.
The combined assessment of analysts suggests that 'Total Benefit /Premium - Aflac Japan' will likely reach 65.3%. The estimate is in contrast to the year-ago figure of 66.9%.
According to the collective judgment of analysts, 'Total Adjusted Expenses/Total Adjusted Revenue - Aflac U.S.' should come in at 38.1%. Compared to the current estimate, the company reported 36.9% in the same quarter of the previous year.
Analysts' assessment points toward 'Total Benefit /Premium - Aflac U.S.' reaching 47.8%. The estimate compares to the year-ago value of 46.7%.
Analysts predict that the 'Total Adjusted Expenses/Total Adjusted Revenue - Aflac Japan' will reach 19.7%. The estimate is in contrast to the year-ago figure of 17.8%.
View all Key Company Metrics for Aflac here>>>Over the past month, shares of Aflac have returned -4.8% versus the Zacks S&P 500 composite's +2.7% change. Currently, AFL carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .